{"id":"07495","slug":"novel-wound-management-system--07495","source":{"id":"07495","dataset":"techtransfer","title":"Novel Wound Management System","description_":"<p>University of Pittsburgh researchers have developed a novel device and associated treatment method to promote wound healing following reconstructive surgery. Designed to form an isolated regenerative space over a wound site, this novel system can convert an off-the-shelf biologic matrix into a graftable vascularized wound bed in vivo through controlled management of the wound microenvironment, including managing hydration or introducing growth factors. This system could revolutionize wound management and allow for the treatment of complex wounds in previously difficult to treat patients.<p><img src=\"https://s3.us-east-1.amazonaws.com/static.tto.c8e.ai/upitt/attachments/07495/0EMVv00000VFUqL.png\"></p></img></p><p><h2>Description</h2>A major challenge in reconstructive surgery is complex wounds where bones, tendons, implantable hardware, or other poorly vascularized structures are exposed. This novel sealed wound chamber system is designed to function as a regenerative bridge whereby avascular or poorly vascularized structures, in combination with a biological scaffold, are converted to vascularized tissue. This vascularized tissue can be used to support grafted tissue and other definitive coverage procedures supporting wound healing and reducing the risk of post-surgical complications.</p><p><h2>Applications</h2>-\tReconstructive surgery\r<br>-\tWound management</p><p><h2>Advantages</h2>Management of complex wounds with exposed avascular or poorly vascularized structures often require vascularized tissue transfer with flap reconstruction. However, flap procedures are high-risk, may be unavailable or unsuitable for some patients and can result in complications at the wound site. Other strategies including negative pressure therapy or scaffold placement do not reliably result in vascularization of the wound site. A lack of reliable, accessible wound healing options following reconstructive surgery remains an unmet need that urgently needs addressing. \r<br>\r<br>This novel system, through controlled wound microenvironment modulation, can convert avascular substrates into graftable vascularized tissue within two months and may remove the need for flap reconstruction altogether in some cases. The system has been designed to be fully sealed around the wound site and can be produced in multiple dimensions to support the treatment of a variety of wound sizes up to and including entire limbs.</p><p><h2>Invention Readiness</h2>Proof-of-concept animal studies have demonstrated this novel system can, over eight weeks, result in vascularized integration of an off-the-shelf biological matrix and durable tissue coverage over an avascular substrate. As a control, traditional treatment using a dermal graft led to incomplete integration and central necrosis. Further work is required.</p><p><h2>IP Status</h2>Patent Pending</p><p></p>","tags":["Regenerative medicine","Surgery","Life Science"],"file_number":"07495","collections":[{"key":516,"name":"Regenerative Medicine"}],"meta_description":"A sealed wound chamber converts avascular substrates into vascularized graft-ready tissue within weeks, potentially避免flaps. Patent-pending.","image_url":"https://s3.us-east-1.amazonaws.com/static.tto.c8e.ai/upitt/attachments/07495/0EMVv00000VFUqL.png","apriori_judge_output":"{\"scores\":{\"novelty\":4.0,\"potential_impact\":4.0,\"readiness\":3.0,\"scalability\":4.0,\"timeliness\":4.0},\"weighted_score\":4.0,\"risks\":[\"Early-stage (POC) with animal data; requires extensive translational work and regulatory clearance.\",\"Potential competition from existing dermal substitutes and flap techniques; manufacturing and cost considerations for off-the-shelf matrix.\"],\"one_sentence_take\":\"High novelty and impact with solid readiness for further development, but requires rigorous translational validation and regulatory pathway planning to reach clinical use.\"}","lead_inventor_name":"Mario Solari","lead_inventor_dept":"Med-Plastic Surgery","therapeutic_areas":[],"therapeutic_indications":[],"custom_tags":[],"all_tech_innovators":["Armin Aryannejad","Fuat Baris Bengur","Chiaki Komatsu","Vanessa Mroueh","Mario Giulio Solari"],"date_submitted":"2026-02-23"},"highlight":{},"matched_queries":null,"score":0.0}